Chemicals & Advanced Materials Global On demand · 24-48h

Global Acorus Calamus Rhizome Extract Market Strategic Research Report

Global Acorus Calamus Rhizome Extract Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Acorus Calamus Rhizome Extract Market
$1572025
7.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Volatile Oil Content: <1%, Volatile Oil Content: 1%–3%, Volatile Oil Content: ≥3%

By Application: Personal Care Products, Cosmetics, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: ICHIMARU PHARCOS(JP), KOEI KOGYO(JP), Maruzen Pharmaceuticals(JP), Wellgreen Herb(CN), Wuhan Lingben Technology(CN), Vigorous-Tech(CN), Sinochem Nanjing(CN), Hunan E.K Herb(CN), Bolise / BKHerb(CN), Vantage(US), Berjé(US), Mother Herbs(IN), Kisalaya Herbals(IN), Vivaan Herbals(IN), Navchetana Kendra(IN), Bioveda Naturals(IN), Chemcopia Ingredients(IN), Pharmika India(IN), FLAVEX Naturextrakte(DE), CONIUNCTA(DE), L.E.V. / Ekstraktu Rupnica(LV), Durae Corporation(KR), Natural Solution(KR), Dermalab(KR), COSEEDBIOPHARM(KR)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 159 pages
Market size 2025
$157
Million USD
Forecast CAGR
7.8%
2025-2032
Forecast 2032
$265.6
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Acorus Calamus Rhizome Extract market size is predicted to grow from US$ 157 million in 2025 to US$ 264 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.

Acorus calamus rhizome extract refers to a mixture of plant-derived active ingredients obtained from the dried rhizomes of plants belonging to the *Acorus* genus (family Araceae) through processes such as solvent extraction, aqueous extraction, or supercritical fluid extraction. It primarily contains volatile oils (such as α-asarone and β-asarone), flavonoids, and various terpenoid compounds. Possessing biological activities such as antioxidant, sedative-soothing, and skin-conditioning properties, it is frequently utilized in traditional herbal medicine formulations, functional cosmetics, and aromatherapy products.

The value chain for Acorus calamus rhizome extract comprises three segments: upstream cultivation and raw material supply (involving cultivation bases, wild harvesting, and seedling propagation); midstream extraction and processing (producing volatile oils and standardized extracts via steam distillation, solvent extraction, or supercritical CO₂ processes); and downstream applications (encompassing traditional Chinese medicine formulations, functional cosmetics, aromatherapy products, and certain dietary supplement formulators). Specifically, the upstream raw material cultivation segment is subject to geographical dependency and fluctuations in active ingredient content; consequently, it exhibits relatively low overall added value, with gross margins typically ranging from 15% to 30%. The midstream extraction and processing segment—due to its involvement in volatile oil separation and active ingredient standardization—faces high technical barriers; its gross margins generally range from 35% to 60%. Conversely, the downstream branding and formulation segment—leveraging efficacy claims and brand premiums—can achieve gross margins of 50% to 80%. Overall, the industry structure is characterized by "low margins at the raw material end, technology-driven value creation in the midstream, and high added value at the downstream branding end."

In 2025, the average price of Acorus calamus rhizome extract is projected to be US$110,000 per ton, with a sales volume of 1,454 tons and a total production capacity of 2,077 tons.

Within the realm of functional botanical ingredients, Acorus calamus rhizome extract embodies a distinctive dual nature: a foundation rooted in traditional medicinal usage, coupled with modern extensions of its application. Its core value stems from the biological activities conferred by its volatile oil constituents—particularly compounds such as asarone ethers—which exhibit sedative, antioxidant, and certain neuromodulatory properties. This profile establishes a solid foundation for its consistent application in Traditional Chinese Medicine formulations, aromatherapy, and soothing skincare products. From an industrial perspective, the utilization of this extract remains predominantly empirical; standardized validation of its mechanisms of action and the accumulation of clinical data are currently relatively limited. Furthermore, its consistency and suitability for large-scale application face significant challenges due to variations in raw material origin and plant variety, as well as the inherent instability of its volatile components. Nevertheless, driven by advancements in the analysis of botanical active ingredients, the refinement of standardized extraction processes, and the growing trend of "emotional wellness" within functional cosmetics, *Acorus* rhizome extract is poised to evolve from a traditional herbal auxiliary ingredient into a sophisticated botanical active ingredient with clearly defined functional attributes.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Acorus Calamus Rhizome Extract market?

What factors are driving Acorus Calamus Rhizome Extract market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Acorus Calamus Rhizome Extract market opportunities vary by end market size?

How does Acorus Calamus Rhizome Extract break out by Type, by Application?

This report presents a comprehensive overview of the global Acorus Calamus Rhizome Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Volatile Oil Content: <1%
  • Volatile Oil Content: 1%–3%
  • Volatile Oil Content: ≥3%

Segment by Grade

  • Pharmaceutical Grade
  • Cosmetic Grade
  • Aromatherapy Grade

Segment by Product Form

  • Crude Extract
  • Standardized Extract
  • Essential Oil Grade

Segment by Application

  • Personal Care Products
  • Cosmetics
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Acorus Calamus Rhizome Extract market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Personal Care Products, Cosmetics, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Acorus Calamus Rhizome Extract Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$157
2025
Forecast
$265.6
2032
CAGR
7.8%
2025–2032
Regions
5
global
Key companies
ICHIMARU PHARCOS(JP)KOEI KOGYO(JP)Maruzen Pharmaceuticals(JP)Wellgreen Herb(CN)Wuhan Lingben Technology(CN)Vigorous-Tech(CN)Sinochem Nanjing(CN)Hunan E.K Herb(CN)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Volatile Oil Content: <1%Volatile Oil Content: 1%–3%Volatile Oil Content: ≥3%
By Application
Personal Care ProductsCosmeticsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Volatile Oil Content: <1%
  • 3.1.3 Volatile Oil Content: 1%–3%
  • 3.1.4 Volatile Oil Content: ≥3%
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Personal Care Products
  • 4.1.3 Cosmetics
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 ICHIMARU PHARCOS(JP)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 KOEI KOGYO(JP)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Maruzen Pharmaceuticals(JP)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Wellgreen Herb(CN)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Wuhan Lingben Technology(CN)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Vigorous-Tech(CN)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Sinochem Nanjing(CN)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Hunan E.K Herb(CN)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Bolise / BKHerb(CN)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Vantage(US)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Berjé(US)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Mother Herbs(IN)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Kisalaya Herbals(IN)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Vivaan Herbals(IN)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Navchetana Kendra(IN)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Bioveda Naturals(IN)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Chemcopia Ingredients(IN)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Pharmika India(IN)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 FLAVEX Naturextrakte(DE)
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 CONIUNCTA(DE)
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 L.E.V. / Ekstraktu Rupnica(LV)
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Durae Corporation(KR)
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Natural Solution(KR)
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Dermalab(KR)
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 COSEEDBIOPHARM(KR)
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Acorus Calamus Rhizome Extract market size?
The global Acorus Calamus Rhizome Extract market is estimated at US$ 157 million in 2025 (base year) and is projected to reach US$ 264 million by 2032.
What growth rate is expected for the Acorus Calamus Rhizome Extract market through 2032?
The market is expected to grow at a CAGR of 7.8% from 2026 to 2032, expanding from US$ 157 million in 2025 to US$ 264 million in 2032, roughly 1.7 times its base-year value.
How is Acorus Calamus Rhizome Extract defined?
Acorus calamus rhizome extract refers to a mixture of plant-derived active ingredients obtained from the dried rhizomes of plants belonging to the *Acorus* genus (family Araceae) through processes such as solvent extraction, aqueous extraction, or supercritical fluid extraction. It primarily contains volatile oils (such as α-asarone and β-asarone), flavonoids, and various terpenoid compounds.
What are the main segments of the Acorus Calamus Rhizome Extract market by type?
By type, the market is segmented into Volatile Oil Content: <1%, Volatile Oil Content: 1%–3% and Volatile Oil Content: ≥3%.
Which applications drive demand in the Acorus Calamus Rhizome Extract market?
Key applications covered include Personal Care Products, Cosmetics and Others.
Who are the key players in the Acorus Calamus Rhizome Extract market?
Key players profiled include ICHIMARU PHARCOS(JP), KOEI KOGYO(JP), Maruzen Pharmaceuticals(JP), Wellgreen Herb(CN), Wuhan Lingben Technology(CN), Vigorous-Tech(CN), Sinochem Nanjing(CN) and Hunan E.K Herb(CN), among 25 companies covered in total.
Which regions and countries are covered for Acorus Calamus Rhizome Extract?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Acorus Calamus Rhizome Extract market?
Overall, the industry structure is characterized by "low margins at the raw material end, technology-driven value creation in the midstream, and high added value at the downstream branding end."
What challenges does the Acorus Calamus Rhizome Extract market face?
It primarily contains volatile oils (such as α-asarone and β-asarone), flavonoids, and various terpenoid compounds.
Who should buy the Acorus Calamus Rhizome Extract market report?
The report is intended for manufacturers and solution providers, distributors and end users in Personal Care Products, Cosmetics and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Acorus Calamus Rhizome Extract market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.